Does OBINUTUZUMAB Cause Rash? 264 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Rash have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.9% of all adverse event reports for OBINUTUZUMAB.
264
Reports of Rash with OBINUTUZUMAB
1.9%
of all OBINUTUZUMAB reports
19
Deaths
82
Hospitalizations
How Dangerous Is Rash From OBINUTUZUMAB?
Of the 264 reports, 19 (7.2%) resulted in death, 82 (31.1%) required hospitalization, and 7 (2.7%) were considered life-threatening.
Is Rash Listed in the Official Label?
Yes, Rash is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Rash?
DUPILUMAB (30,895)
ADALIMUMAB (18,690)
LENALIDOMIDE (15,794)
ADAPALENE (15,709)
METHOTREXATE (15,519)
ETANERCEPT (15,381)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,630)
TOCILIZUMAB (12,327)
ABATACEPT (12,168)
RITUXIMAB (12,102)
Which OBINUTUZUMAB Alternatives Have Lower Rash Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE